Literature DB >> 2475922

Enhanced erythrocyte aggregability in occlusive cerebrovascular disease.

N Tanahashi1, F Gotoh, M Tomita, T Shinohara, Y Terayama, B Mihara, K Ohta, M Nara.   

Abstract

We measured the rate of erythrocyte aggregation using our whole-blood aggregometer in 80 patients with occlusive cerebrovascular disease during the acute and chronic phases. We compared the data with values for 38 age-matched healthy controls. Mean +/- SD erythrocyte aggregability of the patients during both the acute phase (0.145 +/- 0.21/sec, n = 35) and the chronic phase (0.139 +/- 0.21/sec, n = 45) was higher than that in the controls (0.123 +/- 0.21/sec, n = 38; p less than 0.01). Erythrocyte aggregability was positively correlated with the plasma concentration of globulin and fibrinogen and inversely correlated with the albumin:globulin ratio. However, these correlations did not necessarily exclude the possibility that some unknown substance(s) released from ischemic tissue might enhance erythrocyte aggregability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475922     DOI: 10.1161/01.str.20.9.1202

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Influence of plasma proteins on erythrocyte aggregation in three mammalian species.

Authors:  M I Spengler; M Rasia
Journal:  Vet Res Commun       Date:  2001-10       Impact factor: 2.459

2.  First experience in application of heparin-induced extracorporeal LDL precipitation (H.E.L.P.) in acute thromboembolic stroke.

Authors:  H Lechner; M Walzl; B Walzl; G Kleinert
Journal:  Ital J Neurol Sci       Date:  1993-04

3.  Albumin-globulin ratio and mortality in patients on peritoneal dialysis: a retrospective study.

Authors:  Fenfen Peng; Lingzhi Sun; Ting Chen; Yan Zhu; Weidong Zhou; Peilin Li; Yihua Chen; Yiyi Zhuang; Qianyin Huang; Haibo Long
Journal:  BMC Nephrol       Date:  2020-02-14       Impact factor: 2.388

4.  Erythrocyte membrane affinity chromatography, solid-phase extraction and UPLC-QTOF-MS/MS to screen active ingredients of Buyang Huanwu decoction.

Authors:  Aiming Yu; Huazhu Zheng; Xiangli Yan; Shengxin Wang; Xiao Shen; Haozhen Zheng; Yingjiao Meng; Lisheng Wang
Journal:  RSC Adv       Date:  2019-09-17       Impact factor: 4.036

5.  Association of albumin, fibrinogen, and modified proteins with acute coronary syndrome.

Authors:  Nabila Nawar Binti; Nourin Ferdausi; Md Eahsanul Karim Anik; Laila Noor Islam
Journal:  PLoS One       Date:  2022-07-26       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.